These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

427 related articles for article (PubMed ID: 29548627)

  • 1. The epidemiology and risk factor of carbapenem-resistant enterobacteriaceae colonization and infections: Case control study in a single institute in Japan.
    Asai N; Sakanashi D; Suematsu H; Kato H; Hagihara M; Nishiyama N; Koizumi Y; Yamagishi Y; Mikamo H
    J Infect Chemother; 2018 Jul; 24(7):505-509. PubMed ID: 29548627
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fecal carriage of carbapenem-resistant Enterobacteriaceae in a Chinese university hospital.
    Zhao ZC; Xu XH; Liu MB; Wu J; Lin J; Li B
    Am J Infect Control; 2014 May; 42(5):e61-4. PubMed ID: 24773806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carbapenem-resistant Enterobacteriaceae colonization and infection in critically ill patients: a retrospective matched cohort comparison with non-carriers.
    Dickstein Y; Edelman R; Dror T; Hussein K; Bar-Lavie Y; Paul M
    J Hosp Infect; 2016 Sep; 94(1):54-9. PubMed ID: 27392978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of, and risk factors for, carriage of carbapenem-resistant Enterobacteriaceae among hospitalized patients in Japan.
    Yamamoto N; Asada R; Kawahara R; Hagiya H; Akeda Y; Shanmugakani RK; Yoshida H; Yukawa S; Yamamoto K; Takayama Y; Ohnishi H; Taniguchi T; Matsuoka T; Matsunami K; Nishi I; Kase T; Hamada S; Tomono K
    J Hosp Infect; 2017 Nov; 97(3):212-217. PubMed ID: 28736270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidemiology and risk factors for carbapenem-resistant Enterobacteriaceae colonisation and infections: case-controlled study from an academic medical center in a southern area of China.
    Fang L; Lu X; Xu H; Ma X; Chen Y; Liu Y; Hong G; Liang X
    Pathog Dis; 2019 Jun; 77(4):. PubMed ID: 31281931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multicenter Study of the Risk Factors for Colonization or Infection with Carbapenem-Resistant Enterobacteriaceae in Children.
    Chiotos K; Tamma PD; Flett KB; Naumann M; Karandikar MV; Bilker WB; Zaoutis T; Han JH
    Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28971864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors for fecal carriage of IMP-6-producing Enterobacteriaceae at a long-term care hospital in Japan: A follow-up report from the northern Osaka multicentre study group.
    Hagiya H; Yamamoto N; Kawahara R; Akeda Y; Shanmugakani RK; Ueda A; Nishi I; Asada R; Yoshida H; Tomono K
    J Infect Chemother; 2018 Sep; 24(9):769-772. PubMed ID: 29656900
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Screening of nursing home residents for colonization with carbapenem-resistant Enterobacteriaceae admitted to acute care hospitals: Incidence and risk factors.
    Cunha CB; Kassakian SZ; Chan R; Tenover FC; Ziakas P; Chapin KC; Mermel LA
    Am J Infect Control; 2016 Feb; 44(2):126-30. PubMed ID: 26631643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors of Persistent Carbapenem-Resistant Enterobacteriaceae Carriage upon Readmission and Score Development.
    Ciobotaro P; Flaks-Manov N; Oved M; Schattner A; Hoshen M; Ben-Yosef E; Balicer RD; Zimhony O
    Infect Control Hosp Epidemiol; 2016 Feb; 37(2):188-96. PubMed ID: 26750741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors and clinical outcomes for carbapenem-resistant Enterobacteriaceae nosocomial infections.
    Wang Q; Zhang Y; Yao X; Xian H; Liu Y; Li H; Chen H; Wang X; Wang R; Zhao C; Cao B; Wang H
    Eur J Clin Microbiol Infect Dis; 2016 Oct; 35(10):1679-89. PubMed ID: 27401905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fecal carriage of carbapenem-resistant
    Mohan B; Prasad A; Kaur H; Hallur V; Gautam N; Taneja N
    Indian J Med Microbiol; 2017; 35(4):555-562. PubMed ID: 29405149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk Factors for Recurrence of Carbapenem-Resistant Enterobacteriaceae Carriage: Case-Control Study.
    Bart Y; Paul M; Eluk O; Geffen Y; Rabino G; Hussein K
    Infect Control Hosp Epidemiol; 2015 Aug; 36(8):936-41. PubMed ID: 25869912
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors Associated to Prevalence and Incidence of Carbapenem-Resistant Enterobacteriaceae Fecal Carriage: A Cohort Study in a Mexican Tertiary Care Hospital.
    Torres-Gonzalez P; Cervera-Hernandez ME; Niembro-Ortega MD; Leal-Vega F; Cruz-Hervert LP; García-García L; Galindo-Fraga A; Martinez-Gamboa A; Bobadilla-Del Valle M; Sifuentes-Osornio J; Ponce-de-Leon A
    PLoS One; 2015; 10(10):e0139883. PubMed ID: 26431402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors and outcomes associated with the isolation of polymyxin B and carbapenem-resistant Enterobacteriaceae spp.: A case-control study.
    Teo JQ; Chang CW; Leck H; Tang CY; Lee SJ; Cai Y; Ong RT; Koh TH; Tan TT; Kwa AL
    Int J Antimicrob Agents; 2019 May; 53(5):657-662. PubMed ID: 30880229
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Natural history and decolonization strategies for ESBL/carbapenem-resistant Enterobacteriaceae carriage: systematic review and meta-analysis.
    Bar-Yoseph H; Hussein K; Braun E; Paul M
    J Antimicrob Chemother; 2016 Oct; 71(10):2729-39. PubMed ID: 27317444
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rate of colonization of health care workers by carbapenem-resistant Enterobacteriaceae in an endemic hospital: A prospective study.
    Bitterman R; Geffen Y; Rabino G; Eluk O; Warman S; Greenblatt AS; Neuberger A; Reisner SA; Hussein K; Paul M
    Am J Infect Control; 2016 Sep; 44(9):1053-4. PubMed ID: 27125914
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Asymptomatic rectal colonization with carbapenem-resistant Enterobacteriaceae and Clostridium difficile among residents of a long-term care facility in New York City.
    Prasad N; Labaze G; Kopacz J; Chwa S; Platis D; Pan CX; Russo D; LaBombardi VJ; Osorio G; Pollack S; Kreiswirth BN; Chen L; Urban C; Segal-Maurer S
    Am J Infect Control; 2016 May; 44(5):525-32. PubMed ID: 26796684
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors associated to prevalence and treatment of carbapenem-resistant Enterobacteriaceae infections: a seven years retrospective study in three tertiary care hospitals.
    Pang F; Jia XQ; Zhao QG; Zhang Y
    Ann Clin Microbiol Antimicrob; 2018 Mar; 17(1):13. PubMed ID: 29571291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors associated with carriage of carbapenem-non-susceptible Enterobacteriaceaein North-Eastern France and outcomes of infected patients.
    Muggeo A; Guillard T; Barbe C; Thierry A; Bajolet O; Vernet-Garnier V; Limelette A; Brasme L; De Champs C;
    J Antimicrob Chemother; 2017 May; 72(5):1496-1501. PubMed ID: 28158526
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical characteristics of carbapenem-resistant
    Sun Y; Zheng H; Zhang JL; Yu LX; Wang B; Gao W; Cai JZ; Liu YH
    Zhonghua Er Ke Za Zhi; 2020 Aug; 58(8):640-645. PubMed ID: 32842384
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 22.